Gastroenterology
News
Stage esophageal cancer after neoadjuvant chemo
Key clinical point: Tumor stage after completion of neoadjuvant chemotherapy is a much more important predictor of survival than is initial tumor...
News
TCGA investigators propose four subtypes of gastric cancer
News
Angiogenic kinase inhibitor receives orphan drug designation for hepatocellular carcinoma
News
Everolimus fails to improve HCC survival
Key clinical point: Despite the "strong scientific rationale and preclinical data," everolimus failed to improve outcomes in advanced HCC. Major...
News
Neoadjuvant chemoradiotherapy fails to boost survival
Key clinical point: Don’t postpone surgery for esophageal cancer to perform chemoradiotherapy.Major finding: Median overall survival was 31.8...
Conference Coverage
Vascular reconstruction may have a role in pancreatic adenocarcinoma resection
Key clinical point: Performing a Whipple on borderline T3 lesions with vascular invasion may allow for an increased amount of surgical resections....
News
Genetic marker for better colon cancer prognosis halved among African Americans
Key clinical point: Racial disparity in colon cancer mortality may be due in part to biological differences in tumor type.Major finding: The...
Conference Coverage
Refining prognosis in small intestinal neuroendocrine tumors
Key clinical point: The extent of lymph node involvement provides important independent prognostic information in patients with early-stage, T1,...
News
Vaccine-chemo combination boosts immunotherapy in pancreatic cancer
Key clinical point: A therapeutic vaccine combined with low-dose chemotherapy converted pancreatic ductal adenocarcinomas into immunogenic cancers...
Conference Coverage
Screen for Barrett’s in all with central obesity?
Key clinical point: The current recommended strategy of screening for Barrett’s esophagus on the basis of symptoms of gastroesophageal reflux is...
News
Targeting inflammation improved survival for some patients with advanced pancreatic cancer
Major finding: Median overall survival of patients with metastatic pancreatic cancer with CRP levels above 13 mg/L treated with ruxolitinib and...